These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34169661)

  • 21. Doxorubicin-Near infrared dye conjugate induces immunogenic cell death to enhance cancer immunotherapy.
    Jin C; Wang Y; Li Y; Li J; Zhou S; Yu J; Wang Z; Yu Y; Zhang H; Wang D; He Z; Wang Y
    Int J Pharm; 2021 Sep; 607():121027. PubMed ID: 34418473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer.
    Lee SJ; Yang H; Kim WR; Lee YS; Lee WS; Kong SJ; Lee HJ; Kim JH; Cheon J; Kang B; Chon HJ; Kim C
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34145029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded
    Wei B; Pan J; Yuan R; Shao B; Wang Y; Guo X; Zhou S
    Nano Lett; 2021 May; 21(10):4231-4240. PubMed ID: 33998789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional Nanoparticles Boost Cancer Immunotherapy Based on Modulating the Immunosuppressive Tumor Microenvironment.
    Li J; Zhao M; Sun M; Wu S; Zhang H; Dai Y; Wang D
    ACS Appl Mater Interfaces; 2020 Nov; 12(45):50734-50747. PubMed ID: 33124808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal.
    Wang Z; Chen L; Ma Y; Li X; Hu A; Wang H; Wang W; Li X; Tian B; Dong J
    J Nanobiotechnology; 2021 Aug; 19(1):243. PubMed ID: 34384429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy.
    Mao Q; Min J; Zeng R; Liu H; Li H; Zhang C; Zheng A; Lin J; Liu X; Wu M
    Theranostics; 2022; 12(14):6088-6105. PubMed ID: 36168633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring Photosensitizer.
    Wang M; Wu M; Liu X; Shao S; Huang J; Liu B; Liang T
    Adv Sci (Weinh); 2022 Oct; 9(29):e2202914. PubMed ID: 35981886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifunctional Nano-Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death.
    Chen Q; Li C; Wang Q
    Small Methods; 2023 May; 7(5):e2201457. PubMed ID: 36703555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy.
    Duan X; Chan C; Lin W
    Angew Chem Int Ed Engl; 2019 Jan; 58(3):670-680. PubMed ID: 30016571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymer-lipid hybrid nanovesicle-enabled combination of immunogenic chemotherapy and RNAi-mediated PD-L1 knockdown elicits antitumor immunity against melanoma.
    Wang C; Shi X; Song H; Zhang C; Wang X; Huang P; Dong A; Zhang Y; Kong D; Wang W
    Biomaterials; 2021 Jan; 268():120579. PubMed ID: 33278683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Near-Infrared Photoimmunotherapy of Cancer.
    Kobayashi H; Choyke PL
    Acc Chem Res; 2019 Aug; 52(8):2332-2339. PubMed ID: 31335117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ZnO-based multifunctional nanocomposites to inhibit progression and metastasis of melanoma by eliciting antitumor immunity via immunogenic cell death.
    Zhang Y; Guo C; Liu L; Xu J; Jiang H; Li D; Lan J; Li J; Yang J; Tu Q; Sun X; Alamgir M; Chen X; Shen G; Zhu J; Tao J
    Theranostics; 2020; 10(24):11197-11214. PubMed ID: 33042278
    [No Abstract]   [Full Text] [Related]  

  • 34. The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses.
    Aaes TL; Vandenabeele P
    Cell Death Differ; 2021 Mar; 28(3):843-860. PubMed ID: 33214663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
    Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
    Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promotion of ICD via Nanotechnology.
    Qin Y; Zhang H; Li Y; Xie T; Yan S; Wang J; Qu J; Ouyang F; Lv S; Guo Z; Wei H; Yu CY
    Macromol Biosci; 2023 Sep; 23(9):e2300093. PubMed ID: 37114599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy.
    Cruickshank B; Giacomantonio M; Marcato P; McFarland S; Pol J; Gujar S
    Front Immunol; 2018; 9():654. PubMed ID: 29666625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor microenvironment-triggered
    Ding B; Zheng P; Li D; Wang M; Jiang F; Wang Z; Ma P; Lin J
    Nanoscale; 2021 Jun; 13(24):10906-10915. PubMed ID: 34128036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augmented by anti-PD-1 therapy for durable anticancer responses in an immunologically active murine tumor model.
    Hsu MA; Okamura SM; De Magalhaes Filho CD; Bergeron DM; Rodriguez A; West M; Yadav D; Heim R; Fong JJ; Garcia-Guzman M
    Cancer Immunol Immunother; 2023 Jan; 72(1):151-168. PubMed ID: 35776159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
    Liu D; Chen B; Mo Y; Wang Z; Qi T; Zhang Q; Wang Y
    Nano Lett; 2019 Oct; 19(10):6964-6976. PubMed ID: 31518149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.